Genomics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	160 Pages	Fortune Business Insights Pvt. Ltd.	September, 2024	FOB19185523

Best Price Guarantee
Price	from $4,850
Length	160 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	September, 2024
SKU	FOB19185523

Genomics Market

Growth Factors of Genomics Market

The Genomics Market size was valued at USD 27.75 billion in 2023. The market is projected to be worth USD 30.75 billion in 2024 and reach USD 80.17 billion by 2032, exhibiting a CAGR of 12.7% during the forecast period of 2024-2032.

The COVID-19 pandemic considerably impacted the genomics market, driving rapid enhancements and adoption of genomic technologies. The name for for genomics surged as governments and healthcare establishments depended on genetic sequencing to tune virus mutations and expand vaccines. Companies supplying genomic attempting out and analytics noticed sizable increase, at the same time as investment in genomics studies elevated globally. The pandemic highlighted the importance of genomic generation in expertise pathogens and making equipped for destiny health crises, main to extended improvements and collaborations throughout the biotech quarter. This has in the end improved the position of genomics in healthcare, diagnostics, and custom designed medicine.

One key fashion in the genomics marketplace is the upward thrust of direct-to-customer (DTC) genetic checking out. Consumers are more and more interested in information their genetic make-up for insights into health, ancestry, and predispositions to nice ailments. DTC groups like 23andMe and AncestryDNA have acquired popularity because of the convenience of at-home trying out kits, paired with advanced genetic evaluation equipment. As a quit result, genomics has come to be extra available to the general public, fostering a broader understanding of genetics and private health, even as simultaneously using innovation in customized treatment.

A predominant using factor in the again of the increase of the genomics marketplace is the falling cost of DNA sequencing. Technological improvements have notably reduced the charge of sequencing a human genome from millions of dollars to only a few hundred. This affordability has opened the door for great genomic studies, permitting researchers and healthcare vendors to mix genomic facts into medical practices. Lower charges have additionally endorsed biopharma organizations to apply genomics in drug improvement, helping in the discovery of extra targeted and effective treatments. The accessibility of inexpensive sequencing is propelling the genomics marketplace ahead.

Comprehensive Analysis of Genomics Market

The Genomics Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by type, by application, by technology, by end user. By Type include Products , Services. By Technology include Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Microarray, Sanger Sequencing, Others. By Application include Diagnostics, Research, Others. By End User include Research Institutes ,Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs).

The North America region lead the Genomics Market share by benefitting a market size of USD 12.13 billion The rapid adoption of new sequencing technologies and shift towards personalized medicines are expected to render a leading position to North America .

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.

January 2024 – Gencove and Ferris Genomics announced the collaboration for end-to-stop genomics sequencing services.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 12.7% from 2024-2032

Unit Value (USD billion)

Segmentation By Type

- Products

Instruments & Software
Consumables

- Services

By Technology

- Polymerase Chain Reaction (PCR)

- Next-generation Sequencing (NGS)

- Microarray

- Sanger Sequencing

- Others

By Application

- Diagnostics

- Research

- Others

By End User

- Research Institutes

- Healthcare Facilities & Diagnostic Centers

- Pharmaceutical & Biotechnological Companies

- Contract Research Organization (CROs)

By Region

- North America (By Type, Technology, Application, End User, and Country)

U.S.
Canada

- Europe (By Type, Technology, Application, End User, and Country/Sub-region)

U.K.
Germany
France
Italy
Spain
Rest of Europe

- Asia Pacific (By Type, Technology, Application, End User, and Country/Sub-region)

Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific

- Latin America (By Type, Technology, Application, End User, and Country/Sub-region)

Brazil
Mexico
Rest of Latin America

- Middle East & Africa (By Type, Technology, Application, End User, and Country/Sub-region)

GCC
South Africa
Rest of Middle East & Africa

Please Note:

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Overview of Genomic Projects – For Key Countries; 4.2. Overview of Genomic Services; 4.3. New Product Launches, By Key Players; 4.4. Key Industry Developments - Mergers, Acquisitions and Partnerships; 4.5. Impact of COVID-19 on the Market
5. Global Genomics Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Type; 5.1.1. Products; 5.1.1.1. Instruments & Software; 5.1.1.2. Consumables; 5.1.2. Services; 5.2. Market Analysis, Insights and Forecast – By Technology; 5.2.1. Polymerase Chain Reaction (PCR); 5.2.2. Next-generation Sequencing (NGS); 5.2.3. Microarray; 5.2.4. Sanger Sequencing; 5.2.5. Others; 5.3. Market Analysis, Insights and Forecast – By Application; 5.3.1. Diagnostics; 5.3.2. Research; 5.3.3. Others; 5.4. Market Analysis, Insights and Forecast – By End User; 5.4.1. Research Institutes; 5.4.2. Healthcare Facilities & Diagnostic Centers; 5.4.3. Pharmaceutical & Biotechnological Companies; 5.4.4. Contact Research Organizations (CROs); 5.5. Market Analysis, Insights and Forecast – By Region; 5.5.1. North America; 5.5.2. Europe; 5.5.3. Asia Pacific; 5.5.4. Latin America; 5.5.5. Middle East & Africa
6. North America Genomics Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Type; 6.1.1. Products; 6.1.1.1. Instruments & Software; 6.1.1.2. Consumables; 6.1.2. Services; 6.2. Market Analysis, Insights and Forecast – By Technology; 6.2.1. Polymerase Chain Reaction (PCR); 6.2.2. Next-generation Sequencing (NGS); 6.2.3. Microarray; 6.2.4. Sanger Sequencing; 6.2.5. Others; 6.3. Market Analysis, Insights and Forecast – By Application; 6.3.1. Diagnostics; 6.3.2. Research; 6.3.3. Others; 6.4. Market Analysis, Insights and Forecast – By End User; 6.4.1. Research Institutes; 6.4.2. Healthcare Facilities & Diagnostic Centers; 6.4.3. Pharmaceutical & Biotechnological Companies; 6.4.4. Contact Research Organizations (CROs); 6.5. Market Analysis, Insights and Forecast – By Country; 6.5.1. U.S.; 6.5.2. Canada
7. Europe Genomics Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Type; 7.1.1. Products; 7.1.1.1. Instruments & Software; 7.1.1.2. Consumables; 7.1.2. Services; 7.2. Market Analysis, Insights and Forecast – By Technology; 7.2.1. Polymerase Chain Reaction (PCR); 7.2.2. Next-generation Sequencing (NGS); 7.2.3. Microarray; 7.2.4. Sanger Sequencing; 7.2.5. Others; 7.3. Market Analysis, Insights and Forecast – By Application; 7.3.1. Diagnostics; 7.3.2. Research; 7.3.3. Others; 7.4. Market Analysis, Insights and Forecast – By End User; 7.4.1. Research Institutes; 7.4.2. Healthcare Facilities & Diagnostic Centers; 7.4.3. Pharmaceutical & Biotechnological Companies; 7.4.4. Contact Research Organizations (CROs); 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.5.1. U.K.; 7.5.2. Germany; 7.5.3. France; 7.5.4. Spain; 7.5.5. Italy; 7.5.6. Rest of Europe
8. Asia Pacific Genomics Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Type; 8.1.1. Products; 8.1.1.1. Instruments & Software; 8.1.1.2. Consumables; 8.1.2. Services; 8.2. Market Analysis, Insights and Forecast – By Technology; 8.2.1. Polymerase Chain Reaction (PCR); 8.2.2. Next-generation Sequencing (NGS); 8.2.3. Microarray; 8.2.4. Sanger Sequencing; 8.2.5. Others; 8.3. Market Analysis, Insights and Forecast – By Application; 8.3.1. Diagnostics; 8.3.2. Research; 8.3.3. Others; 8.4. Market Analysis, Insights and Forecast – By End User; 8.4.1. Research Institutes; 8.4.2. Healthcare Facilities & Diagnostic Centers; 8.4.3. Pharmaceutical & Biotechnological Companies; 8.4.4. Contact Research Organizations (CROs); 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.5.1. Japan; 8.5.2. China; 8.5.3. India; 8.5.4. Australia; 8.5.5. Southeast Asia; 8.5.6. Rest of Asia Pacific
9. Latin America Genomics Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Type; 9.1.1. Products; 9.1.1.1. Instruments & Software; 9.1.1.2. Consumables; 9.1.2. Services; 9.2. Market Analysis, Insights and Forecast – By Technology; 9.2.1. Polymerase Chain Reaction (PCR); 9.2.2. Next-generation Sequencing (NGS); 9.2.3. Microarray; 9.2.4. Sanger Sequencing; 9.2.5. Others; 9.3. Market Analysis, Insights and Forecast – By Application; 9.3.1. Diagnostics; 9.3.2. Research; 9.3.3. Others; 9.4. Market Analysis, Insights and Forecast – By End User; 9.4.1. Research Institutes; 9.4.2. Healthcare Facilities & Diagnostic Centers; 9.4.3. Pharmaceutical & Biotechnological Companies; 9.4.4. Contact Research Organizations (CROs); 9.5. Market Analysis, Insights and Forecast – By Country/ Sub-regions; 9.5.1. Brazil; 9.5.2. Mexico; 9.5.3. Rest of Latin America
10. Middle East & Africa Genomics Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Type; 10.1.1. Products; 10.1.1.1. Instruments & Software; 10.1.1.2. Consumables; 10.1.2. Services; 10.2. Market Analysis, Insights and Forecast – By Technology; 10.2.1. Polymerase Chain Reaction (PCR); 10.2.2. Next-generation Sequencing (NGS); 10.2.3. Microarray; 10.2.4. Sanger Sequencing; 10.2.5. Others; 10.3. Market Analysis, Insights and Forecast – By Application; 10.3.1. Diagnostics; 10.3.2. Research; 10.3.3. Others; 10.4. Market Analysis, Insights and Forecast – By End User; 10.4.1. Research Institutes; 10.4.2. Healthcare Facilities & Diagnostic Centers; 10.4.3. Pharmaceutical & Biotechnological Companies; 10.4.4. Contact Research Organizations (CROs); 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.5.1. South Africa; 10.5.2. GCC; 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Illumina Inc.; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Thermo Fisher Scientific Inc.; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Agilent Technologies, Inc.; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. F.Hoffmann-La Roche Ltd.; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Oxford Nanopore Technologies; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Danaher; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. BGI; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. IntegraGen; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 11.2.9. General Electric Company; 11.2.9.1. Overview; 11.2.9.2. Products & Services; 11.2.9.3. SWOT Analysis; 11.2.9.4. Recent Developments; 11.2.9.5. Strategies; 11.2.9.6. Financials (Based on Availability)